INTRODUCTION
Natural products have been used as sources of active components of drugs (Cragg and Newman, 2013) . Compounds isolated from plants function as models that provide the chemical backbones used in modern techniques, such as combinatorial chemistry techniques, for the discovery of novel drug candidates (Harvey, 2007; Cragg and Newman, 2013) .
The high diversity of existing chemical agents can be ascribed to their discovery in natural products. With over 43,000 known plant species, Brazil has high biodiversity, and approximately 2000 of these species are unique to the country (Brazil, 2006 (Brazil, , 2010 .
Campomanesia adamantium (Cambess.) O. Berg. belongs to the Myrtaceae family. Native to Brazilian cerrado, C. adamantium is found in 7 states in the central region of the country (Sobral et al., 2014) . This species is characterized by a shrub form with height in the range of 60-80 cm, small cream-white flowers, and rounded yellowish-green fruit. The fruit is commonly known as guavira, gabiroba, or guabiroba, and appears from September to December (Avidos and Ferreira, 2000) . Species belonging to the Campomanesia genus have been shown to have medicinal properties, such as anti-inflammatory, antidiarrheal, antiseptic (Rodrigues and Carvalho, 2001; Brandelli et al., 2011; de Souza et al., 2014) , and antioxidant activities (Ramos et al., 2007; Coutinho et al., 2008; Rufino et al., 2010; Pascoal et al., 2011) , which are mainly attributed to the presence of phenolic compounds, flavonoids, chalcones, carotenoids, and vitamins.
Fruit and infusions of C. adamantium are widely consumed by different populations in the form of fresh or fermented beverages, which are commonly consumed by the indigenous population (Duarte et al., 2009; Brandelli et al., 2011) . Therefore, studies focused on the genetic toxicity of C. adamantium are necessary to ensure its safety for consumption and validate its use for the prevention and treatment of diseases. This study evaluated C. adamantium for its acute toxicity, mutagenicity/antimutagenicity, and ability to induce apoptosis in Swiss mice.
MATERIAL AND METHODS

DNA damage-inducing agent
Cyclophosphamide (CP) (Fosfaseron ® , Itaca Laboratórios Ltda., REG M.S. No. 1.2603.0056.002-1; Batch 063020, Brazil) was prepared in 0.9% NaCl sterile saline solution at pH 7.4 and administered as a single dose at 100 mg/kg body weight (bw) by intraperitoneal (ip) injection.
Collection and identification of the plant material
Plant material was collected in December 2011 at Horto de Plantas Medicinais -HPM, Universidade Federal da Grande Dourados -UFGD, in Dourados, Mato Grosso do Sul (MS), Brazil. The sample was identified by Dr. Maria do Carmo Vieira and a voucher specimen was deposited at the UFGD herbarium (record No. 2196).
C. adamantium hydroethanolic extract
C. adamantium extract was provided by Prof. Dr. Claudia Andréa Lima Cardoso, Universidade Estadual de Mato Grosso do Sul -UEMS. C. adamantium leaves were dried in a forced-air circulating oven at 45° ± 5°C and ground in a Wiley knife mill. The dried leaves were macerated in ethanol:water (70:30, v:v) at room temperature for 7 days. After this period, the extract was filtered and subjected to 2 additional extractions using the same procedure. After 21 days, the filtrate was collected, concentrated using a vacuum rotary evaporator (FISATOM), and then dried in a laminar flow hood until a specific yield of 28.1% was obtained. The extract was stored at 4°C and protected from light.
The extract was administered as a single dose at 30, 100, and 300 mg/kg (bw) by gavage. Doses were selected based on doses reported in studies by Fernandes and Vargas (2003) and de Souza et al. (2014) .
Experimental design
A total of 140 sexually mature male Swiss mice (Mus musculus) obtained from Central Animal Facility of Biological and Health Sciences Center, Universidade Federal de Mato Grosso do Sul (UFMS), were divided into 14 experimental groups (N = 10 animals per group). The animals were housed in polypropylene cages lined with wood shavings and kept in ventilated racks (ALESCO ® ), and fed with commercial food (Nuvital ® ) and filtered water ad libitum. Lighting was maintained as a 12-h light:dark period; the temperature was set at 22° ± 2°C and humidity at 55 ± 10%. The experiment was conducted according to the guidelines of the Universal Declaration of Animal Rights and with the approval of Animal Research Ethics Committee of UFMS (Protocol No. 399/2012) . Treatments and collection of biological material for assays were performed as shown in Figure 1 .
Biometric data evaluation and clinical signs of toxicity
The animals were weighed at the beginning and end of the experiment. Gain or loss of animal weight was calculated as the difference between the final and initial weights. Clinical observation for signs or characteristics of toxicity was performed in accordance to the guidelines of the Organization for Economic Co-Operation and Development (OECD, 2008) .
Micronucleus assay using peripheral blood samples
Micronucleus assay was performed following a protocol described by Hayashi et al. (1990) and adapted by Oliveira et al. (2009) . Peripheral blood samples (20 µL) were deposited on a slide pre-coated with 20 µL acridine orange (1 mg/mL) and covered with a coverslip. The slides were stored at -20°C for 15 days. For each animal, 2000 cells were analyzed using a fluorescence microscope at 400X magnification (Bioval ® , Model L 2000A), a 420-490-nm excitation wavelength, and a 520-nm barrier filter.
Spleen phagocytosis evaluation
One-third of the spleen was macerated with 400 µL 0.9% NaCl sterile solution to obtain a cell suspension. One hundred microliters of the cell suspension was deposited on a slide containing 20 µL acridine orange (1 mg/mL) and covered with a coverslip. The slides were stored at -20°C until analysis. For each animal, 200 cells were analyzed using a fluorescence microscope at 400X magnification, a 420-490-nm excitation wavelength, and a 520-nm barrier filter. The analysis was performed as previously described by Hayashi et al. (1990) and adapted by de Lima et al. (2013) .
Cell death by apoptosis
Cell death by apoptosis was investigated in different organs such as the liver, kidney, and spleen. Cell suspension was obtained from one-third of the spleen, one lobe of the liver, and the right kidney by macerating them separately with 200 µL 0.9% sterile saline solution using a crucible and pestle. One hundred microliters of the cell suspension was used to prepare a smear on a histological slide. The slides were fixed in Carnoy's solution for 5 min and then subjected to a gradient of decreasing concentrations of ethanol (95-25%), washed with McIlvaine's buffer for 5 min, stained with 0.01% acridine orange for 5 min, and then washed again with buffer. A total of 100 cells per animal were assessed for apoptosis based on DNA fragmentation patterns described by Navarro et al. (2014) .
Statistical analysis
Results are reported as means ± standard error of mean (SE). Data were analyzed by ANOVA or the Tukey parametric test using the Graph Pad Instat software (version 3.02; Graph-Pad Software Inc., San Diego, CA, USA). P < 0.05 was considered to indicate significance.
RESULTS
C. adamantium extract does not induce acute toxicity
There were no significant differences in weight gain between the mice treated with C. adamantium extract with or without CP (Table 1 ). In addition, there were no clinical signs of acute toxicity, such as changes in skin and fur, eyes and mucous membranes, respiratory function, somatomotor activity, and behavior (OECD, 2008) . CP = cyclophosphamide; Camp = Campomanesia adamantium. Same superscript letters indicate absence of significant differences (ANOVA/Tukey; P > 0.05). 
Hydroethanolic extract is mutagenic and reduces DNA damage induced by CP
Mutagenic and antimutagenic activities were evaluated by performing the micronucleus assay in peripheral blood after 24, 48, and 72 h of treatment. After 24 h, there was a slight increase in the average number of micronuclei at doses of 30 and 100 mg/kg (7.70 ± 1.38 and 6.10 ± 1.76, respectively) compared to the number in the control (1.10 ± 0.45); however, the differences were not statistically significant. The highest dose (300 mg/kg) resulted in the lowest average micronucleus number among the groups that received the extract (2.00 ± 0.53). After 48 and 72 h, micronucleus averages decreased and no significant differences were observed among the C. adamantium and control groups.
For antimutagenesis experiments, C. adamantium extract was combined with DNA damageinducing agent CP and three different protocols were used: pre-treatment, simultaneous treatment, and post-treatment. Results showed that there was a reduction of micronucleus frequency in all three experiments and at different exposure time points compared to the frequency associated with CP treatment. For all of these protocols, the greatest reduction was obtained at 72 h (Table 2) .
Different superscript letters indicate statistically significant differences (ANOVA/Tukey; P < 0.05). 
C. adamantium increases splenic phagocytic activity
Compared to the control group, the C. adamantium-treated groups showed increased phagocytosis in the spleen (39.37 ± 2.90, 38.50 ± 2.32, and 58.00 ± 1.87 for the 30, 100, and 300 mg/kg doses, respectively, vs 20.37 ± 0.80 in the control group); the intergroup difference was statistically significant.
CP increased phagocytic activity in the spleen (119.25 ± 3.22). Combined treatment with the extract significantly increased the average number of phagocytosed cells in relation to the number in the positive control group (Figure 2) . 
Apoptosis increased in the kidney, spleen, and liver
Cell death by apoptosis was investigated by morphological analysis in different types of organs, such as the spleen, liver, and kidneys. The extract induced apoptosis in all the organs studied.
In groups treated with the combined treatments, there was a significant reduction in apoptotic cell frequency in all organs compared to that in the CP groups. More pronounced reduction was observed after treatments (Figure 3) . 
DISCUSSION
The widespread use of plants to treat diseases is an important indicator that plants can serve as sources of new chemical compounds with therapeutic potential. C. adamantium is a common species in Brazilian cerrado, and its anti-inflammatory, antidiarrheal, antiseptic, and antioxidant activities, reported by the native population, have been confirmed in previous studies (Ramos et al., 2007; Coutinho et al., 2008; Pascoal et al., 2011; Ferreira et al., 2013; de Souza et al., 2014) . However, few studies on its mutagenic potential have been reported.
In this study, no clinical signs of toxicity were observed after C. adamantium extract administration in the experimental animals. These findings are consistent with those of de , who observed low toxicity of C. adamantium fruit extracts, for which the lethal dose (LD 50 ) was higher than 2000 mg/kg. Furthermore, this extract was also classified as having low toxicity in Guidelines of the Organization for Economic Co-Operation and Development (OECD, 2008) . Ramos et al. (2007) evaluated the toxicity of hexane extract of C. adamantium leaves in Artemia sp and concluded that 2 mg/mL extract was not toxic, since no microcrustacean death was observed.
Mutagenicity evaluation showed an increase in the average number of micronuclei at 30 and 100 mg/kg after 24 h. The highest concentration (300 mg/kg) resulted in the lowest average number among groups that received the extract. Micronuclei are derived from acentric chromosomal fragments, chromatids, or whole chromosomes that do not migrate along the spindle during anaphase and stay in the cytoplasm. These components are surrounded by a nuclear membrane and acquire the same morphological characteristics as the nucleus, with the exception of size (Fenech et al., 2011) . One cause of micronucleus formation is the effect of chemical agents on DNA, which was first reported by Klein and Klein (1952) in Ehrlich tumor cells treated with colchicine. These compounds induce single-and double-strand DNA breaks, which generate DNA fragments that form micronuclei if they were not repaired (Fenech et al., 2011) .
The increases in the average number of micronuclei at doses of 30 and 100 mg/kg after 24 h may be related to the extract potential to cause DNA damage. In this case, DNA damage could not be repaired and resulted in micronuclei. At 24 h after the administration of the 300 mg/ kg, the extent of damage was greater than that produced at the lower doses. This observation may be explained by comparing results from micronuclei and splenic phagocytosis, which showed increased phagocytic activity in spleens from C. adamantium-treated mice. It is known that the spleen removes defective cells from the bloodstream, including micronucleated cells (de Lima et al., 2013) . Therefore, this finding supports the hypothesis that the extract is capable of inducing cellular DNA damage.
Extracts also increased the number of apoptotic cells, which are consistent with previously discussed data. In particular, extract at 300 mg/kg resulted in highest apoptosis average, which suggests that higher concentrations are directly related to increased non-reparable cell damage that leads to cell death. This speculation is supported by the effect observed at lower doses; the initial damage caused by the extract is less extensive and can still be detected as increased number of micronuclei over 24 h. After 48 and 72 h, micronucleus frequency decreased, and damage may be detected as increased number of apoptotic cells. Pascoal et al. (2014) reported the cytotoxic potential of ethanolic extract from leaves and fruit of C. adamantium, and a chalcone isolated from leaves, referred to as cardamonin. In a prostate cancer cell line (PC-3), leaf extract demonstrated optimal antiproliferative response, which was associated with higher level of cardamonin. In addition, chalcone induced apoptosis along with DNA fragmentation after 6 h of exposure. These findings are consistent with our data that showed increased damage at shorter post-exposure times.
Previous study using aqueous leaf extract in Salmonella/microsome test demonstrated the mutagenic potential of Campomanesia xanthocarpa in a dose-dependent manner, in TA97 strain (frameshift mutation) without metabolic activation (Fernandes and Vargas, 2003) .
Our data showed a considerable decrease in micronucleus formation in all groups treated with extract and CP, which suggests that extract has antimutagenic activity. Considering the other above-mentioned data, which suggests that extract is capable of producing potentially nonrepairable DNA damage and increases cell death by apoptosis, these findings suggest that: i) extract may chemically inactivate CP (desmutagenic activity) and/or ii) extract directly affects the metabolism of CP, increasing its excretion.
CP is an alkylating agent that induces intrastrand and interstrand DNA crosslinks. However, CP is a prodrug that is metabolized by cytochrome P450 family of hepatic microsomal enzymes, specifically mixed-function oxidases, to form the active molecule (Cohen and Jao, 1970; Pinto et al., 2009) . P450 metabolic system is the most well-known drug metabolism system (Cohen and Jao, 1970) . Plant extracts affect drug metabolism. When taken concomitantly, they can directly affect enzyme activity, inhibiting or increasing drug metabolism, which may result in increased clearance rates and side effects (Hu et al., 2005) .
The main components of C. adamantium extract are chalcones, flavonones, and phenolic compounds (Ramos et al., 2007; Coutinho et al., 2008; Ferreira et al., 2013; Pascoal et al., 2011 Pascoal et al., , 2014 . Compounds belonging to the chemical classes such as flavonones and chalcones are known to affect the metabolizing activity of microsomal fraction of liver (Shimada et al., 2010; Liu et al., 2013) . Additionally, they can also affect the phase 2 reactions and modulating activity and/ or expression of glutathione-S-transferases (GSTs) (Cabrera et al., 2010; Boušová and Skálová, 2012) . These enzymes are involved in detoxification of several chemotherapeutic agents and their metabolites, including CP (Pinto et al., 2009) . Taking these findings into consideration, decreased micronucleus frequency and apoptosis in combined treatment groups may be related to the ability of C. adamantium extract components to increase GST activity, thereby causing a significant increase in the excretion of CP and its metabolites. Pre-treatment and simultaneous treatments differed significantly from positive control. In contrast, post-treatment groups had lower means similar to negative control and groups that only received extract.
Apoptotic cell death process basically involves two steps, cell condensation and fragmentation (formation of apoptotic bodies) and elimination of apoptotic bodies by phagocytes . It is difficult to estimate the amount of time required to complete this process. Analysis of several experimental models suggests that it is reasonably fast, approximately 24 h (Kerr, 1971; Crawford et al., 1972; Wyllie et al., 1973) . Therefore, lower means observed for the post-treatment group may not only be related to extract effect on CP metabolism, but may also be related to the removal of apoptotic cells by the body because in this study time interval between CP treatment and execution of the apoptosis assay was longer than that in other studies.
Similarly, phagocytic activity increased significantly. This effect was most likely owing to additive effect of both extract and CP, because both are capable of inducing DNA damage and consequently producing defective cells that are removed from circulation by the spleen.
A short-term exposure to C. adamantium hydroethanolic extract is capable of causing potentially non-repairable DNA damage, which leads to cell death. Extract components may have a modulatory effect on microsomal enzymes, especially GSTs, thereby directly affecting metabolism of CP. Our data suggest caution in concomitant consumption of preparations containing C. adamantium leaves with drugs, since it may decrease drug efficacy through metabolic modulations produced by extract components.
Conflicts of interest
The authors declare no conflict of interest.
